Atheromatous renovascular disease (ARVD) is a common and challenging disease. It is increasingly associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), hypertension and cardiovascular burden. Controversy exists regarding the safest investigative methods as well as optimum treatment of this condition. In this review, we provide an overview of ARVD and discuss the challenges still remaining.
No takes yet. Share an insight, caveat, or question.
Chrysochou et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: